Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Does AbbVie Have 'Unclean Hands' From Building Humira Patent Thicket? Judge Allows Discovery

Jun 20 2018

• By Brenda Sandburg

Patents concept words. Folder concept. Ring binders.

Related Content

Humira's 'Unique' Number Of Patents Makes Biosimilar Entry Risky, Pfizer Says

Apr 11 2018

The New 180 Days? Humira Biosimilar Deals Give Amgen 150-Day Jump On Samsung

Apr 06 2018

Humira Biosimilar: Boehringer Faces Same Launch Hurdles As Amgen

Aug 28 2017

HCV Patent Case: With "Unclean Hands," Merck Can't Collect Jury Award From Gilead

Jun 08 2016

Related Companies

Boehringer Ingelheim GmbH

AbbVie Inc.

Amgen, Inc.

Pfizer Inc.

Samsung Bioepis Co., Ltd.

Gilead Sciences, Inc.

Merck & Co., Inc.

Additional Topics

United States Biosimilars Intellectual Property Policy Legal Issues BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window